Gene Liau

STOK

Gene Liau serves as EVP Research & Preclinical Dev at Stoke Therapeutics, Inc. (STOK). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$327.5K

Net Position

Net Seller

$327.5K

Companies Traded

STOK

Active Period

Mar 2021

1 total trades

Most Recent

Sell STOK

Mar 4, 2021 · $327.5K

Gene Liau's Insider Trading at Stoke Therapeutics, Inc. (STOK)

Buys

0 · $0.00

Sells

1 · $327.5K

Total Shares Bought

Total Shares Sold

5,195

STOK Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 4, 2021	Sell	5,195	$63.05	$327.5K	24,251

Related Insiders

Barry Ticho

officer: CHIEF MEDICAL OFFICER

STOKSell · Apr 3, 2026

Jonathan Allan

officer: GENERAL COUNSEL & CORP SEC

STOKSell · Mar 24, 2026

Thomas Leggett

officer: Chief Financial Officer

STOKSell · Mar 19, 2026

Jason Hoitt

officer: Chief Patient Officer

STOKSell · Mar 19, 2026

LEVIN ARTHUR A

director

STOKSell · Mar 17, 2026

Adrian R. Krainer

Director

STOKSell · Mar 12, 2026

TZIANABOS ARTHUR

director, officer: Interim Executive Chair

STOKSell · Mar 12, 2026

Edward M. MD Kaye

Director

STOKSell · Dec 8, 2025

Explore More Insider Trading Data

STOK Insider Trading Activity

View all insider trades at Stoke Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity